 |
Taro Pharmaceutical Industries Ltd |
Company profile |
|
Analysis : [Random Walk] [Default Prediction] [Fundamental Analysis]
|
Price Prediction |
No random walk data for 2008
|
Default Prediction for 2004-12-31 |
|
Default prediction by Z-Score (what's this?).
Sector Industry
 
View the other companies in the same industry : Biotechnology & Drugs
Alternative Z-Scores designed for non-public companies (i.e. take these with a grain of salt):
For manufacuring companies:
Sector Industry
  |
For non-manufacturing companies:
Sector Industry
  |
|
Fundamental Analysis for 2004- |
|
Fundamental Analysis measures (what's this?).
Date of financial statements used: 2004-12-31 |
| Book Value : |
$297.724 M |
Internal Value : |
$297.724 M |
Working Capital : |
$201.585 M |
| Debt to Asset Ratio : |
0.472 |
Current Ratio: |
0.395 |
Turnover Ratio: |
13.125 |
| Net Margins : |
102.620 |
EPS : |
0.378 |
P/E ratio : |
28.042 |
| P/B ratio : |
1.043 |
ROE : |
0.037 |
ROA : |
0.016 |
|
